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Introduction
Kawasaki disease (KD) is an acute self-limited systemic
vasculitis relatively common in childhood. In Japan, last
published survey shows an incidence up to 239.6/105
children <5 years old (yo). In Madrid (Spain) a retro-
spective study with no well defined reference area
showed an incidence of 15.1/105 children <5yo.
Objectives
To ascertain the incidence and clinical features of KD in
Catalonia Catalonia, autonomous region in northeast
Spain with 7.5 million inhabitants, over a prospective
period of one year.
Methods
Observational population-based study including all Cata-
lan hospitals with Pediatric Units, both public and pri-
vate management. Prospective communication of new
cases of KD was performed from March 2013 to March
2014. The presence of coronary aneurysms (CA) in
echocardiology was based in the body surface area
according to the American Heart Association. Giant CA
was considered if the CA was higher than 8mm.
Results
The study included 33 different hospitals from Catalonia.
Over the one-year study period 49 new cases of KD were
collected. The annual incidence was 4.1/105 children <14yo
and 12.3/105 children <5yo (mean age 34±23months (m),
range 3.3-105.1m). There were not differences between
boys and girls. Mean delay between onset of the disease
and diagnostic was 8.6±9.8 days. Ethnic distribution was:
Caucasian 42 patients (85.7%), North African 4 (8.1%),
Amerindian 2 (4%) and Asian 1 (2%). Distribution of classi-
cal manifestations for KD was: fever in 100% of patients,
changes in extremities: edema and erythema 51%% and
desquamation 44.9%, exanthema 85.7%, conjunctival injec-
tion 91.8%, changes in lips and oral cavity 77.5% and
lymphadenopathy 24.8%. Other clinical findings reported
were: sterile pyuria in 10 (20%) patients, nausea and vomit-
ing in 13 (26.5%), abdominal pain in 12 (24.4%), gallbladder
distention in 1 (2%), transaminase elevation in 13 (26.5%),
jaundice in 3 (6.1%), irritability in 20 (40.8%), and arthritis
or arthralgia in 13 (26.5%). Cardiologic findings were: peri-
vascular brightness of the coronary wall in 8 (16.3%)
patients, myocarditis in 1 (2%), mitral regurgitation in
3 (6%) and CA in 8 (16.3%) patients, disappearing before
the 2nd moth of disease in 2 patients. No gyant CA were
reported. Intravenous immunoglobulin (IVIG) was admi-
nistered in 47 (95.9%) patients with response to the 1st
dose in 40 (91.6%). Day of IVIG administration was 7.8
±3.3. Abciximab was administered in 2 patients. 97.9% of
patients received anti-platelet dose aspirin in the convales-
cent phase.
Conclusion
During the prospective period incidence of KD in Catalo-
nia (Spain) was higher than the one ascertained in the ret-
rospective analysis. Further analysis may be performed in
order to know if this is due to a better diagnosis, a better
registry o a real incidence increase. It seems to be a higher
incidence of CA in our cohort despite high rates of treat-
ment response. Further analysis is required. Incidence
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rate, other clinical features and treatment plans are similar




1Rheumatology Unit, Department of Pediatrics, Hospital Sant Joan de Déu,
Esplugues de Llobregat, Spain. 2Rheumatology Unit, Department of
Pediatrics, Hospital Parc Taulí, Sabadell, Spain. 3Cardiology Department,
Hospital Sant Joan de Déu, Esplugues de Llobregat, Spain. 4Pediatrics
Department, Hospital Vall d’Hebron, Barcelona, Spain. 5Pediatrics Department,
Consorci Sanitari de Terrassa, Terrassa, Spain. 6Pediatrics Department,
Hospital Arnau de VIlanova, Lleida, Spain. 7Pediatrics Department, Hospital
Germans Tiras i Pujol, Badalona, Spain. 8Pediatrics Department, Hospital de
Nens, Barcelona, Spain. 9Pediatrics Department, Hospital Joan XIII, Tarragona,
Spain.
Published: 17 September 2014
doi:10.1186/1546-0096-12-S1-P349
Cite this article as: Sanchez-Manubens et al.: Prospective analysis of
Kawasaki disease cases in Catalonia (Spain) from March 2013 to March
2014. Pediatric Rheumatology 2014 12(Suppl 1):P349.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sanchez-Manubens et al. Pediatric Rheumatology 2014, 12(Suppl 1):P349
http://www.ped-rheum.com/content/12/S1/P349
Page 2 of 2
